HP Cash Equivalents and Available For Sale Securities, Fair Value, Excluding Accrued Interest decreased by 34.7% to $1.31B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 19.0%, from $1.62B to $1.31B. Over 4 years (FY 2021 to FY 2025), Cash Equivalents and Available For Sale Securities, Fair Value, Excluding Accrued Interest shows a downward trend with a -10.4% CAGR.
other_cash_equivalents_and_available_for_sale_securities_91923a| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.12B | $3.35B | $4.20B | $2.26B | $882.00M | $1.04B | $901.00M | $2.57B | $1.63B | $1.79B | $2.15B | $2.53B | $1.62B | $2.14B | $2.31B | $2.01B | $1.31B |
| QoQ Change | — | +7.5% | +25.2% | -46.3% | -60.9% | +17.6% | -13.1% | +185.2% | -36.7% | +9.8% | +20.7% | +17.5% | -35.9% | +31.8% | +7.9% | -12.7% | -34.7% |
| YoY Change | — | — | — | -27.7% | — | -69.1% | -78.5% | +13.9% | +84.4% | +72.1% | +139.1% | -1.5% | -0.2% | +19.7% | +7.0% | -20.5% | -19.0% |